Intercepting Takayasu Arteritis Before Structural Decay: The Pre-Structural Takayasu Ambulatory Risk (P-STAR) Triage Matrix Hypothesis for Primary Care

Takayasu Arteritis (TAK) is characterized by a prolonged median diagnostic delay of 3 to 5 years, exposing young individuals to irreversible catastrophic endpoints. While the 2022 ACR/EULAR classification criteria serve as an unparalleled gold standard for epidemiological research and clinical trials, an unmet clinical need persists at the frontlines of primary care for an operationally robust triage tool to capture at-risk patients during the reversible, pre-structural mural inflammatory phase. Rationale & Conceptual Framework: TAK initiates as an endarteritis of the vasa vasorum long before fixed luminal narrowing occurs. Crucially, up to 30% of patients with active mural disease exhibit discordantly normal ESR and CRP levels. Epidemiologically, deploying low-specificity screening tools for rare diseases mathematically triggers an overwhelming "false-positive paradox." Utilizing Decision Curve Analysis (DCA) as a conceptual framework, the clinical cost of a false-negative outcome (irreversible tissue infarction) astronomically outweighs a non-invasive false-positive referral. Thus, an Asymmetric Cost Matrix critically warrants a targeted triage pathway. Methodological Architecture (P-STAR): The Pre-Structural Takayasu Ambulatory Risk (P-STAR) model is engineered as a rapid ambulatory triage gate, conceptually designed for implementation as a Digital Clinical Decision Support System (CDSS): ● Prerequisite Gate: Age <50 years with a presentation of Pyrexia of Unknown Origin (PUO) or chronic unexplained neck pain, mandating the strict operational exclusion of critical vascular mimics (e.g., TIPIC Syndrome). ● Domain 1 (Inflammatory/Constitutional; Max +2): Prioritizes tissue harbingers like Erythema Nodosum to capture biochemically silent mural inflammation. ● Domain 2 (High-Specificity Hemodynamics; Max +3): Captures high-specificity ischemic signs while algorithmically enforcing a single-highest-item rule for collinearity suppression. ● Domain 3 (Sonographic Mural Pathology; Max +3): Fast-track expert verification of early B-mode localized carotid wall edema or circumferential wall thickening ≥1.1 mm (+3). Score Action Thresholds: Actions range from conservative monitoring with a 3-to-6-month safety net (Score 1-2) to triggering immediate Vessel-Wall MRI and a pre-treatment safety hold (Score 5-8). Intermediate scores (3-4) act as an "administrative red flag" to expedite expert sonographic confirmation. Ultimately, P-STAR shifts the diagnostic paradigm from retrospective classification to proactive frontline interception, aiming to eradicate the catastrophic diagnostic lag. Keywords: Takayasu Arteritis; Diagnostic Lag; Targeted Triage; Primary Care; Pre-Structural Interception; Pyrexia of Unknown Origin; Decision Curve Analysis; HLA-B*52; TIPIC Syndrome. 6. Conclusion and Future Directions The P-STAR Triage Matrix is proposed as an innovative, complementary architectural framework for global primary care. By deploying algorithmic guardrails (Collinearity Suppression via CDSS), logistical pragmatism (Administrative Red Flags), and robust clinical safety nets, it respects the foundations laid by existing classification criteria while aiming to bridge the catastrophic diagnostic gap in Takayasu Arteritis. Moving forward, this heuristic framework requires rigorous in silico validation utilizing artificial intelligence and large retrospective Electronic Health Record (EHR) datasets to empirically calibrate its weighted variables and solidify its role in intercepting this devastating disease worldwide.